Bibliography
- Ichijo H, Nishida E, Irie K, Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275(5296):90-4
- Matsukawa J, Matsuzawa A, Takeda K, Ichijo H. The ASK1-MAP kinase cascades in mammalian stress response. J Biochem 2004;136(3):261-5
- Takeda K, Matsuzawa A, Nishitoh H, Ichijo H. Roles of MAPKKK ASK1 in stress-induced cell death. Cell Struct Funct 2003;28(1):23-9
- Fujisawa T, Takeda K, Ichijo H. ASK family proteins in stress response and disease. Mol Biotechnol 2007;37(1):13-18
- Kaji T, Yoshida S, Kawai K, ASK3, a novel member of the apoptosis signal-regulating kinase family, is essential for stress-induced cell death in HeLa cells. Biochem Biophys Res Commun 2010;395(2):213-18
- Takeda K, Shimozono R, Noguchi T, Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J Biol Chem 2007;282(10):7522-31
- Iriyama T, Takeda K, Nakamura H, ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesis. EMBO J 2009;28(7):843-53
- Tobiume K, Matsuzawa A, Takahashi T, ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001;2(3):222-8
- Volynets GP, Chekanov MO, Synyugin AR, Identification of 3H-naphtho[1,2,3-de]quinoline-2,7-diones as inhibitors of apoptosis signal-regulating kinase 1 (ASK1). J Med Chem 2011;54(8):2680-6
- Volynets GP, Bdzhola VG, Kukharenko OP, Yarmoluk SM. Identification of ASK1 small-molecule inhibitors. Ukr Biochim J 2010;82(5):41-50
- Wang BH, Xu GY, Ho PY, Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac myocyte hypertrophy and fibroblast collagen synthesis stimulated by angiotensin II- and TGFbeta: therapeutic potential of ASK1 inhibitors in myocardial remodelling. Circulation 2011;124:A12344
- Philpott KL, Brackenborough K, Skaper SD, ASK1 kinase-dead knock-in mice and models of neurodegeneration. Alzheimer's & Dementia J Alzheimer's Association 2008;4(Suppl 4):T229-30
- Takeda Pharmaceutical Co. Ltd. Fused Heterocyclic Compound. WO2008016131;2008
- Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2009123986;2009
- Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2010008843;2010
- Takeda Pharmaceutical Co. Ltd. Pyrazolo [1, 5-A] Pyrimidine Derivatives As Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2011041293;2011
- Takeda Pharmaceutical Co. Ltd. Apoptosis Signal-Regulating Kinase 1 Inhibitors. WO2011097079;2011
- Gilead Sciences, Inc. Methods for identifying ask1 inhibitors useful for preventing and/or treating cardiovascular diseases. US20070276050;2007
- Gilead Sciences, Inc. Apoptosis Signal-Regulating Kinase Inhibitors. WO2012003387;2012
- Gilead Sciences, Inc. Apoptosis Signal-Regulating Kinase Inhibitors. WO2011008709;2011
- Merck Serono SA. Triazolopyridine compounds and their use as ASK inhibitors. WO2009027283;2009
- Convergence Pharmaceuticals, Ltd. ASK1 inhibiting pyrrolopyrimidine derivatives. WO2012080735;2012
- Bamborough P, Drewry D, Harper G, Assessment of chemical coverage of kinome space and its implications for kinase drug discovery. J Med Chem 2008;51(24):7898-914
- Convergence Pharmaceuticals the pipeline. Available from: http://www.convergencepharma.com/index.asp?page_id=16
- Brownlees J, Patel S, Hatcher J, PT 148 Apoptosis Signal-Regulating Kinase (ASK1): A Novel Target For Inflammatory Pain 13th World Congress on Pain 2010 See. Available from: http://iasp.omnibooksonline.com/2010/